Dr Kathryn Fletcher has 15+ years of experience in research and evaluation. She has worked across academic, government and industry roles in a clinical and research capacity and has published over 65 peer-reviewed manuscripts, four book chapters and a key Government Report. Kathryn currently works as Senior Research Associate at the National Centre for Clinical Research on Emerging Drugs, focusing on clinical trial design and implementation. Her program of research focuses on mental health (with expertise in mood disorders) and comorbid substance use disorders. She is currently working on developing innovative treatments for methamphetamine use disorder, including psychedelic-assisted psychotherapy. As a clinical psychologist and researcher, she is passionate about evidence-based, scalable solutions that have meaningful, real-world social impact.